InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Flavin John l, 董事. Officer active across 1 company, notably Pyxis Oncology, Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 31 March 2022. The latest transaction was filed on 26 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John L. Flavin is a Board Member at Pyxis Oncology, Inc. He plays an active role in the governance of the company, bringing his expertise in biotechnology and strategy. Flavin contributes to important decision-making and the strategic direction of Pyxis Oncology.